Joseph C. Galante

Joseph C. Galante, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Cumberland Pharmaceuticals Inc, Pinnacle Financial Partners Inc and Avenue Financial Holdings, Inc. In total, 26 filings cover trades dated from 26 January 2016 to 18 March 2026.

No open-market sale appears; the market trades are 14 purchases worth €70k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 12 share grants.

A typical purchase (the median) is worth €170. Of 14 purchases, 13 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 20 March 2026, the filings show a share grant worth €4,368 in Cumberland Pharmaceuticals Inc. The most recent open-market purchase was published on 23 January 2023, 1,364 days ago. Typically, a trade is published a median of 30 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.